Scott S Terhune
Overview
Explore the profile of Scott S Terhune including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1011
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cataldo K, Roche K, Monti C, Dash R, Murphy E, Terhune S
J Virol
. 2024 Dec;
99(1):e0175124.
PMID: 39655950
Human cytomegalovirus (HCMV) is a betaherpesvirus capable of infecting numerous cell types and persisting throughout an infected individual's life. Disease usually occurs in individuals with compromised or underdeveloped immune systems....
2.
Cataldo K, Roche K, Monti C, Dash R, Murphy E, Terhune S
bioRxiv
. 2024 Nov;
PMID: 39484423
Importance: HCMV infection and reactivation continues to contribute to morbidity and mortality around the world. Antiviral compounds are available but have limitations. Here, we have defined the impact of the...
3.
Adelman J, Sukowaty A, Partridge K, Gawrys J, Terhune S, Ebert A
bioRxiv
. 2024 Sep;
PMID: 39229072
Human cytomegalovirus (HCMV) is a prolific human herpesvirus that infects most individuals by adulthood. While typically asymptomatic in adults, congenital infection can induce serious neurological symptoms including hearing loss, visual...
4.
Monti C, Hong S, Audi S, Lee W, Joshi A, Terhune S, et al.
Am J Physiol Gastrointest Liver Physiol
. 2024 Jun;
327(3):G424-G437.
PMID: 38917324
Ischemia-reperfusion injury (IRI) is an intrinsic risk associated with liver transplantation. Ex vivo hepatic machine perfusion (MP) is an emerging organ preservation technique that can mitigate IRI, especially in livers...
5.
Mokry R, Monti C, Rosas-Rogers S, Schumacher M, Dash R, Terhune S
bioRxiv
. 2024 Apr;
PMID: 38562837
Human cytomegalovirus (HCMV) is a prevalent betaherpesvirus, and infection can lead to a range of symptomatology from mononucleosis to sepsis in immunocompromised individuals. HCMV is also the leading viral cause...
6.
Womack J, Shah V, Audi S, Terhune S, Dash R
Bioinform Adv
. 2024 Mar;
4(1):vbae023.
PMID: 38456125
Summary: Molecular mechanisms of biological functions and disease processes are exceptionally complex, and our ability to interrogate and understand relationships is becoming increasingly dependent on the use of computational modeling....
7.
Shah V, Womack J, Zamora A, Terhune S, Dash R
Annu Int Conf IEEE Eng Med Biol Soc
. 2023 Dec;
2023:1-5.
PMID: 38083755
Immunotherapies have been proven to have significant therapeutic efficacy in the treatment of cancer. The last decade has seen adoptive cell therapies, such as chimeric antigen receptor T-cell (CART-cell) therapy,...
8.
Adelman J, Rosas-Rogers S, Schumacher M, Mokry R, Terhune S, Ebert A
mBio
. 2023 Nov;
14(6):e0225123.
PMID: 37966250
Human cytomegalovirus (HCMV) is a highly prevalent viral pathogen that can cause serious neurological deficits in infants experiencing an infection. Also, as a life-long infection, HCMV has been associated with...
9.
OBrien B, Mokry R, Schumacher M, Rosas-Rogers S, Terhune S, Ebert A
J Virol
. 2023 Oct;
97(10):e0069623.
PMID: 37796129
Human cytomegalovirus (HCMV) infection is the leading cause of non-heritable birth defects worldwide. HCMV readily infects the early progenitor cell population of the developing brain, and we have found that...
10.
Zarrella K, Longmire P, Zeltzer S, Collins-McMillen D, Hancock M, Buehler J, et al.
PLoS Pathog
. 2023 Jun;
19(6):e1011185.
PMID: 37289831
Innate immune responses are crucial for limiting virus infection. However, viruses often hijack our best defenses for viral objectives. Human Cytomegalovirus (HCMV) is a beta herpesvirus which establishes a life-long...